5 Top Stock Trades for Thursday: S&P 500, NFLX, FDX, ROKU >>> READ MORE

Bull’s Eye: Bruker Corp. (BRKR)

BRKR ranks a buy today, based on its recent price action

By Dave Moenning, Proprietor of StateoftheMarkets.com


At StateoftheMarkets.com, we strive to “own the best and ignore the rest” in our equity portfolios. Toward this end, each day we search our database for a “top stock” (a top rated company in terms of earnings strength as well as company and industry performance) that presents a strong technical “set up” and a good entry point.

In short, when our equity team is looking to add a stock to one of our portfolios, the “bull’s eye” stock shown below is generally their first choice.

Company Symbol Industry Stock Rating YTD% Gain S.T. Stop Loss
Bruker Corp BRKR Life Sciences 9.3 +31.51% $19.12

Why We Like The Stock:

Bruker Corp. (BRKR) is our most compelling buy today due to the fact that it is a top-rated stock (in terms of earnings strength and company/industry performance) with a strong technical set-up. Life Sciences  stocks have been strong this year, as evidenced in charts like Illumina (ILMN), Agilent Technologies (A), Pall Corp. (PLL), and BRKR.

BRKR started the year strong, but hit a rough patch from April through June. After bottoming out just south of $16 in July, the stock has turned around, and has been trending higher for the past two and a half months. BRKR recently hit highs of $21 before pulling back $1 to current prices. It is operating well above its 50-day moving average, and seems to be basing right around $20. We are looking for BRKR to exit the oversold stochastic shortly, and make a run back to recent highs. We would be buyers at current prices, or on a pullback back down to the 50-day moving average.

We Would Be Buyers:

At the current price (~$20.00), or on a pullback to the 50-day moving average ($19.58).

Company Profile:

Bruker Corporation is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The company’s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V. In September 2013, the Company announced that it has acquired Prairie Technologies, Inc.

Stock Rating: 9.3

The Stock Rating indicates the combined score of our proprietary Earning Strength and Company Performance models. The rating scale is 0 – 10 with 10 being the highest.

Bruker – Last Three Months


Bruker – Last 12 Months


Bruker – Last Five Years


Looking to trade the Bull’s Eye stock picks? Click here to download our free Special Report, “How We Identify Our “Bull’s Eye” Picks & How You Can Profit Trading Them”

At the time of publication the editor and affiliated companies own the following positions: None

Note: Positions may be bought or sold while this publication is in circulation without notice.

Article printed from InvestorPlace Media, https://investorplace.com/2013/09/bulls-eye-bruker-corp-brkr/.

©2019 InvestorPlace Media, LLC